Building on this success, in 2023, Kwon’s group synthesized a series of AUTOTAC molecules that bind both p62/SQSTM1 and α-synuclein aggregates, which are implicated in the progression of Parkinson’s disease. This evidence concerns the gene SQSTM1 and Parkinson disease.